The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Combination of Daptomycin and Fosfomycin Has Synergistic, Potent, and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus in a Rabbit Model of Experimental Endocarditis
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 62, Issue 6, Pages e02633-17
Publisher
American Society for Microbiology
Online
2018-03-28
DOI
10.1128/aac.02633-17
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Redeploying β-Lactam Antibiotics as a Novel Antivirulence Strategy for the Treatment of Methicillin-ResistantStaphylococcus aureusInfections
- (2016) Elaine M. Waters et al. JOURNAL OF INFECTIOUS DISEASES
- CAMERA2 – combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial
- (2016) Steven Y. C. Tong et al. Trials
- Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus
- (2015) A. del Río et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Penicillin Binding Protein 1 Is Important in the Compensatory Response of Staphylococcus aureus to Daptomycin-Induced Membrane Damage and Is a Potential Target for β-Lactam–Daptomycin Synergy
- (2015) Andrew D. Berti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
- (2015) Larry M. Baddour et al. CIRCULATION
- 2015 ESC Guidelines for the management of infective endocarditis
- (2015) Gilbert Habib et al. EUROPEAN HEART JOURNAL
- Daptomycin plus fosfomycin versus daptomycin monotherapy in treating MRSA: protocol of a multicentre, randomised, phase III trial
- (2015) E. Shaw et al. BMJ Open
- Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin Plus Ceftaroline
- (2014) George Sakoulas et al. CLINICAL THERAPEUTICS
- β-Lactam Antibiotics Targeting PBP1 Selectively Enhance Daptomycin Activity against Methicillin-Resistant Staphylococcus aureus
- (2013) Andrew D. Berti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- DaptomycinIn VitroActivity against Methicillin-Resistant Staphylococcus aureus Is Enhanced by d-Cycloserine in a Mechanism Associated with a Decrease in Cell Surface Charge
- (2013) O. Gasch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin
- (2013) O. Gasch et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus
- (2013) George Sakoulas et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Mechanisms of daptomycin resistance inStaphylococcus aureus: role of the cell membrane and cell wall
- (2012) Arnold S. Bayer et al. Annals of the New York Academy of Sciences
- High-Dose Daptomycin plus Fosfomycin Is Safe and Effective in Treating Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Endocarditis
- (2012) José M. Miró et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evaluation of the combination of daptomycin and nafcillin against vancomycin-intermediate Staphylococcus aureus
- (2012) S. N. Leonard et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Use of Antistaphylococcal -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding
- (2011) A. Dhand et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Relationship between Susceptibility to Daptomycin In Vitro and Activity In Vivo in a Rabbit Model of Aortic Valve Endocarditis
- (2009) H. F. Chambers et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activities of Daptomycin and Vancomycin Alone and in Combination with Rifampin and Gentamicin against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus Isolates in an Experimental Model of Endocarditis
- (2009) K. L. LaPlante et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century
- (2009) David R. Murdoch ARCHIVES OF INTERNAL MEDICINE
- Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections
- (2009) Nikos Roussos et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Daptomycin Is Effective in Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus
- (2008) F. Marco et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now